Ken Griffin Exicure, Inc. Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
Shares
4 transactions
Others Institutions Holding XCUR
# of Institutions
17Shares Held
766KCall Options Held
0Put Options Held
0-
Abingworth LLP London, X0282KShares$1.07 Million0.11% of portfolio
-
Carlyle Group Inc. Washington, DC282KShares$1.07 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA56.5KShares$215,3370.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA46KShares$175,2670.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.1KShares$152,7540.0% of portfolio
About EXICURE, INC.
- Ticker XCUR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 4,962,580
- Market Cap $18.9M
- Description
- Exicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic and chronic pain. The company has a collaboration, option, and license agreement with AbbVie...